Feeds:
Posts
Comments

Posts Tagged ‘Erectile Dysfunction’

URO TODAY: Having erectile dysfunction prior to prostate cancer surgery does not affect you chances of surviving the treatment, a study shows. READ MORE>

Pre-operative erectile dysfunction is associated with decreased overall survival and survival from causes other than prostate cancer following radical prostatectomy.

However, pre-operative ED was not an independent predictor of overall survival after adjusting for other predictors of survival.

Urologists should carefully assess pre-treatment ED status to enhance appropriate treatment recommendation for men with prostate cancer.

Read Full Post »

URO TODAY: There’s strong evidence pomegranate juice helps reduce erectile dysfunction, according to research at Boston University School of Medicine. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: The American College of Physicians has just issued new guidelines that strongly endorse use of sildenafil (Viagra) and similar drugs for the treatment of erectile dysfunction. READ MORE>

Read Full Post »

URO TODAY: Men with erectile dysfunction before a radical prostatectomy may have a greater risk of death, according to a study of nearly 3000 patients by Johns Hopkins researchers. READ MORE>

Surgeons may consider erectile dysfunction as [a] potential surrogate marker of a shorter life expectancy, but not an absolute surgical contra-indication.

Read Full Post »

URO TODAY: For some men, trying to get an erection is a major hurdle – but for others there is the opposite problem.

Researchers at Rush University Medical Center, Chicago, have been testing a treatment for what’s called recurrent ischemic priapism, or sleep-related erections. READ  MORE>

Ketoconazole and (steroid) prednisone therapy was well tolerated in these eight patients with recurrent ischemic priapism, and with testosterone monitoring and dose titration it was successful in preventing recurrent episodes while preserving sexual function.

Read Full Post »

URO TODAY: Erectile dysfunction following treatment for prostate cancer – particularly radical prostatectomy – is a major quality of life issue that remains unsatisfactorily addressed. Here’s a new look at the issues. READ MORE>

Read Full Post »

URO TODAY: The early use of phosphodiesterase inhibitors after radiotherapy for prostate cancer probably reduces the risk of erectile dysfunction. READ MORE>

Read Full Post »

URO TODAY: The more Viagra a man takes, the greater the likelihood of side effects like headaches, “flushing”, dyspepsia and problems with sight. READ MORE>

A Canadian review found there are no long-term studies looking at the effects of the popular erectile dysfunction treatment.

After looking at nearly 50 short-term studies, the researchers concluded:

In short-term trials, men with erectile dysfunction randomized to sildenafil  (Viagra) had an increased risk of all-cause any adverse events, headache, flushing, dyspepsia, and visual disturbances.

There was a lack of RCTs reporting long-term (>6 months) harms data. The exploration of different modes of dose optimization of sildenafil may be warranted.

Read Full Post »

JULY 24: URO TODAY: Erectile dysfunction drug tadalafil improved performance and satisfaction significantly for men in a US trial, compared with those given a placebo. READ MORE>

Read Full Post »

JULY 13: URO TODAY: Research shows that once-daily tadalafil is effective in men with erectile dysfunction and symptoms of enlarged prostate (BPH), with erectile function improvements comparable to those for the general erectile dysfunction population. READ MORE>

Read Full Post »

Older Posts »